141 related articles for article (PubMed ID: 29434924)
1. Enhanced expression of KIF4A in colorectal cancer is associated with lymph node metastasis.
Matsumoto Y; Saito M; Saito K; Kanke Y; Watanabe Y; Onozawa H; Hayase S; Sakamoto W; Ishigame T; Momma T; Kumamoto K; Ohki S; Takenoshita S
Oncol Lett; 2018 Feb; 15(2):2188-2194. PubMed ID: 29434924
[TBL] [Abstract][Full Text] [Related]
2. KIF4A facilitates cell proliferation via induction of p21-mediated cell cycle progression and promotes metastasis in colorectal cancer.
Hou PF; Jiang T; Chen F; Shi PC; Li HQ; Bai J; Song J
Cell Death Dis; 2018 May; 9(5):477. PubMed ID: 29706624
[TBL] [Abstract][Full Text] [Related]
3. Impact of KIF4A on Cancer Stem Cells and EMT in Lung Cancer and Glioma.
Kahm YJ; Kim IG; Jung U; Lee JH; Kim RK
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067227
[TBL] [Abstract][Full Text] [Related]
4. KIF4A knockdown suppresses ovarian cancer cell proliferation and induces apoptosis by downregulating BUB1 expression.
Jin W; Ye L
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34013367
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of KIF4A in osteosarcoma predicts a poor prognosis and facilitates tumor growth by activation of the MAPK pathway.
Zhu D; Xu X; Zhang M; Wang T
Exp Ther Med; 2021 Nov; 22(5):1339. PubMed ID: 34630693
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus upregulates the expression of kinesin family member 4A.
Zhu CL; Cheng DZ; Liu F; Yan XH; Wu KL; Wang FB; Liu XH
Mol Med Rep; 2015 Sep; 12(3):3503-3507. PubMed ID: 25998931
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of kinesin family member 4A enhanced cell proliferation via activation of Akt signaling and predicted a poor prognosis in hepatocellular carcinoma.
Huang Y; Wang H; Lian Y; Wu X; Zhou L; Wang J; Deng M; Huang Y
Cell Death Dis; 2018 Feb; 9(2):141. PubMed ID: 29396392
[TBL] [Abstract][Full Text] [Related]
8. KIF4A Promotes Clear Cell Renal Cell Carcinoma (ccRCC) Proliferation in vitro and in vivo.
Yang GH; Ren ZX; Yang X; Zhang YG
Onco Targets Ther; 2020; 13():2667-2676. PubMed ID: 32280241
[TBL] [Abstract][Full Text] [Related]
9. FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression.
Hu G; Yan Z; Zhang C; Cheng M; Yan Y; Wang Y; Deng L; Lu Q; Luo S
J Exp Clin Cancer Res; 2019 May; 38(1):188. PubMed ID: 31072351
[TBL] [Abstract][Full Text] [Related]
10. KIF4A promotes the development of bladder cancer by transcriptionally activating the expression of CDCA3.
Zheng P; Wu K; Gao Z; Li H; Li W; Wang X; Shi Z; Xiao F; Wang K; Li Z; Han Q
Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33846765
[TBL] [Abstract][Full Text] [Related]
11. An integrated bioinformatical analysis to evaluate the role of KIF4A as a prognostic biomarker for breast cancer.
Xue D; Cheng P; Han M; Liu X; Xue L; Ye C; Wang K; Huang J
Onco Targets Ther; 2018; 11():4755-4768. PubMed ID: 30127624
[TBL] [Abstract][Full Text] [Related]
12. Impaired DNA double-strand breaks repair by kinesin family member 4A inhibition renders human H1299 non-small-cell lung cancer cells sensitive to cisplatin.
Wan Q; Shen Y; Zhao H; Wang B; Zhao L; Zhang Y; Bu X; Wan M; Shen C
J Cell Physiol; 2019 Jul; 234(7):10360-10371. PubMed ID: 30417376
[TBL] [Abstract][Full Text] [Related]
13. Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer.
Taniwaki M; Takano A; Ishikawa N; Yasui W; Inai K; Nishimura H; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6624-31. PubMed ID: 18006763
[TBL] [Abstract][Full Text] [Related]
14. Upregulate KIF4A Enhances Proliferation, Invasion of Hepatocellular Carcinoma and Indicates poor prognosis Across Human Cancer Types.
Hou G; Dong C; Dong Z; Liu G; Xu H; Chen L; Liu L; Wang H; Zhou W
Sci Rep; 2017 Jun; 7(1):4148. PubMed ID: 28646197
[TBL] [Abstract][Full Text] [Related]
15. Increased KIF4A expression is a potential prognostic factor in prostate cancer.
Gao H; Chen X; Cai Q; Shang Z; Niu Y
Oncol Lett; 2018 May; 15(5):7941-7947. PubMed ID: 29725481
[TBL] [Abstract][Full Text] [Related]
16. Kif4A mediates resistance to neoadjuvant chemoradiotherapy in patients with advanced colorectal cancer via regulating DNA damage response.
Zhang R; Liu S; Gong B; Xie W; Zhao Y; Xu L; Zheng Y; Jin S; Ding C; Xu C; Dong Z
Acta Biochim Biophys Sin (Shanghai); 2022 May; 54(7):940-951. PubMed ID: 35882623
[TBL] [Abstract][Full Text] [Related]
17. KIF4A promotes genomic stability and progression of endometrial cancer through regulation of TPX2 protein degradation.
Zhang J; An L; Zhao R; Shi R; Zhou X; Wei S; Zhang Q; Zhang T; Feng D; Yu Z; Wang H
Mol Carcinog; 2023 Mar; 62(3):303-318. PubMed ID: 36468837
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatic and Experimental Analyses Reveal That KIF4A Is a Biomarker of Therapeutic Sensitivity and Predicts Prognosis in Cervical Cancer Patients.
Wu J; Li L; Zhong H; Zhang HH; Li J; Zhang HB; Zhao YQ; Xu B; Song QB
Curr Med Sci; 2022 Dec; 42(6):1273-1284. PubMed ID: 36260268
[TBL] [Abstract][Full Text] [Related]
19. KIF4A is a promising prognostic marker and correlates with immune infiltration in clear cell renal cell carcinoma.
Li C; Chen J; Su Z
Transl Cancer Res; 2020 Nov; 9(11):7165-7173. PubMed ID: 35117320
[TBL] [Abstract][Full Text] [Related]
20. KIF4A promotes epithelial-mesenchymal transition by activating the TGF-β/SMAD signaling pathway in glioma cells.
Xu Y; Xue G; Zhou L; Wu G; Hu L; Ma S; Zhang J; Li X
Mol Cell Biochem; 2024 Feb; ():. PubMed ID: 38411896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
